跳至主要内容
临床试验/NCT02316847
NCT02316847终止2 期

Multi-center, Open-label, Study of Safety and Tolerability of Chronic Intermittent Usage of Diazepam Nasal Spray in Adolescents and Adult Patients With Cluster Seizures, Including Assessment of Olfaction and Reported Changes in Taste.

Acorda Therapeutics33 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2014年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
126
试验地点
33
主要终点
Olfactory Changes as Measured by the Smell Identification Test (SIT)

研究概览

简要总结

This study will assess long-term safety and tolerability of repeat dose diazepam nasal spray in adolescents and adults with cluster seizures, with a focus on potential local effects (changes in nasal mucosa, olfaction, and taste).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of drug-resistant epilepsy
  • Patients who experience multiple episodes of acute repetitive seizures requiring at least one concomitant antiepileptic drug (AED)
  • Occurrence of at least 3 seizure clusters within the past 12 months, including at least one cluster in the 4 months prior to the Screening Visit
  • A caregiver must consent to participate together with the subject for purposes of observation and data collection
  • The caregiver must be present when the investigational product is administered
  • Screening body weight between 26 to 111 kg, inclusive

排除标准

  • Female subject who is pregnant, breastfeeding, or planning to become pregnant
  • Presence or history of any abnormality or illness that may affect the absorption, distribution, metabolism or elimination of diazepam
  • Known allergy or hypersensitivity to diazepam, related drugs, or any of the formulation components
  • Positive screening test for ethanol or other drugs of abuse
  • Unable to receive medications intranasally

研究组 & 干预措施

diazepam nasal spray (Adults)

Experimental

One dose of diazepam nasal spray is two intranasal sprays; one in each nostril using a nasal spray device. The dose is administered while the subject is sitting up or lying down.

干预措施: diazepam nasal spray (Drug)

Diazepam Nasal Spray (Adolescents)

Experimental

One dose of diazepam nasal spray is two intranasal sprays; one in each nostril using a nasal spray device. The dose is administered while the subject is sitting up or lying down.

干预措施: diazepam nasal spray (Drug)

结局指标

主要结局

Olfactory Changes as Measured by the Smell Identification Test (SIT)

时间窗: Screening, weeks 12, 24, 36, 48 and 51

The SIT is a 50-item multiple-choice standardized test of olfactory function. Scoring of the test in the ability to smell ranges from normal (Normosmia: score 35 - 40 Women; 34 - 40 Men); to inability to smell (Anosmia score 6 - 18); or Malingering (not engaged in the test) ranges 0 - 5.

Change From Baseline (Screening) in Nasal Mucosa.

时间窗: Screening, Weeks 12, 24, 36, 48 and 51

Change from baseline treatment visits using a focused nasal exam was based on a scale of nasal irritation "none" to Grade 4 "septal perforation."

Change in Taste as Measured by a Taste Change Questionnaire

时间窗: Weeks 12, 24

Change in taste questionnaire was administered to subjects at every study visit only if the subject complained of a change in taste or as needed to report a related AE. The taste change profile included sweet, salty, sour, bitter, oily, sharp, chalky, metallic. The subject rated the change on a 10-point scale ranging from a weak change (1) to very strong (10).

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (33)

Loading locations...

相似试验

An Open-Label, Safety and Tolerability Study of... | 临床试验